Urine testing might prove to be an alternative screening test for cervical cancer

October 18, 2004

Urine testing might prove to be an alternative screening test for cervical cancer Seattle -- A study involving 143 women from Senegal, West Africa has shown that a simple urine test might provide an alternative to Pap screening for cervical cancer. In most of the world, cervical cancer is the second leading cause of cancer-related death among women. The routine way to screen for cervical cancer is through Pap screening and pelvic exams.

"More studies involving a much larger group of women need to be done, but we are hopeful about the potential of urine testing as a cost-effective and less-invasive way to screen for cervical cancer," says Dr. Nancy Kiviat, director of Pathology at Harborview Medical Center, a University of Washington Professor of Pathology, and principal investigator of the study.

Kiviat will present her findings October 18 at the American Association for Cancer Research Third Annual International Conference on Frontiers in Cancer Prevention Research at the Washington State Convention and Trade Center in Seattle. Her abstract is titled, "Promoter hypermethylation of tumor suppressor genes in urine from cervical cancer patients."

The study included urine testing of women from Senegal, West Africa. Urine samples were taken from 41 women with negative or low-grade lesions, 72 women with invasive cancer, and 30 women with high-grade lesions. Urine-based detection of abnormal methylation of three genes was used to identify women at risk of cervical cancer. In this limited sample, this approach provided a sensitivity of 53 percent for detection of CIN3/carcinoma in situ and invasive cervical cancer with a specificity of over 90 percent. Ongoing studies are examining the increase in sensitivity provided by the addition of other genes.

"The implications of having a urine-based approach to screen women with a high risk of cervical cancer is enormous," says Kiviat. "In developing countries where Pap screening has not been established due to a lack of infrastructure, a urine-based approach to testing could have a huge impact."
-end-


American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.